The pre-launch phase of the drug commercialization journey is a mission-critical time that weighs heavily on product and patient outcomes. Manufacturers invest in and align on the building blocks of a successful therapeutic debut during this pre-market period—developing the unique value proposition, defining distribution channel strategy, and designing patient support services. But how do you find the right partner to help?
Regardless of your lab's size or scale, there will come a time when you need a customized solution for your media, sera, or reagents. Off-the-shelf lab products are great for many production needs, but scientists often find themselves searching for tailor-made options when the standard catalog doesn't quite fit the project. But there's a catch: With customization comes many considerations. Researchers who thoughtfully explore each one will be best equipped to reap the benefits of customization with minimal risk, cost, and resources.
Considering everything it takes to scale up gene therapy — the platforms, the media, the surfaces, the vessels, the equipment — developing viral vector production processes comes with many challenges. It's no surprise, then, that labs sometimes miss a few things when scaling their gene therapeutics up or out, and those oversights can set projects back. These are common pitfalls — but most researchers don't realize that they're problematic until it's far too late.
Any lab of any size, with the help of the right partners, can customize its process so that it can incorporate future innovations — and in vaccine production, you never know when that next big thing could come along. By following these tips, you can scale your processes and goals without locking yourself into a legacy setup.
For the Einstein Lab and others like it, it's about the love — the love of doing what's right, and the love of science. And those aren't mutually exclusive.
In life sciences, there are more single-use gloves, tips, flasks, and packaging than you can fit in a trash can. On top of that, freezers and faucets run seemingly around the clock—and the energy usage is three times what the average office space puts out. Still, there are sustainable practices that you can adopt. Start with these.
As an amazing muscle that beats about 100,000 times a day, the heart is what keeps us all going—pumping oxygen-rich blood that other organs (like the lungs, brain and kidneys) need to stay healthy. With all the good things your ticker does for you, it deserves some TLC. Here are a few tips worth trying today.
Money doesn’t grow on trees, so how do you get more of it when bills come due? Voluntary insurance, such as a Hospital Indemnity plan, can help. It gives you peace of mind (and extra cash) for life’s most stressful moments.
Imagine beating cancer, only to be then saddled with lingering medical debt. That’s the scenario up to 1 in 3 cancer survivors face, according to a 2017 report from the American Cancer Society (ACS). Combined with the opportunity costs of missing work, medical expenses add up fast — and can leave a lasting financial impact in their wake. This is why it’s important for you and your employees to be familiar with critical illness insurance facts and costs. Here’s what to know.
Young people entering the workforce today may be thinking about more than just their careers, including starting a family and paying off student loans. What they’re much less likely to be thinking about is the fact that, by the time they retire, 1 in 4 will experience some form of disability that makes them unable to work for at least a year. By raising awareness of the prevalence of disability and helping employees learn what they can do to mitigate their risk, you can help give them financial peace of mind.
Reducing wasteful spending will be a key driver of cardiology's economic recovery, as overtreatment and low-value care account for $75.7 billion to $101.2 billion of healthcare's annual financial waste, according to JAMA. Investing in diagnostic accuracy can help cardiologists drive these costs down and improve patient care, saving money and, more importantly, lives.
How can cardiologists check their own biases for the good of their patients? Systemic change starts with small steps and happens in iterations. These are a few strategies that may help.
Of all the poor patient outcomes tied to the novel coronavirus—including ICU stays, severe COVID-19, and death—about half have one factor in common: the patient experienced a cardiac arrhythmia.
In the case of a cardiac event, every minute that passes is precious, and any amount of time that is wasted — whether due to a delayed diagnostic workup or faulty ECG interpretation — can risk lasting damage to muscles and organs. And yet, many cardiologists spend those initial minutes pursuing diagnoses that end up being wrong.